COMMUNIQUÉS West-GlobeNewswire

SELLAS Life Sciences Announces Expedited Development Path for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Following Feedback from FDA
28/11/2018
Agreement on new open-label randomized registrational Phase 3 study in patients in second complete remission (CR2) poised to reduce sample size, time to primary endpoint and costs Fast-Track and Orphan Drug designations [...]
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer
28/11/2018
IRVINE, Calif., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced that is has signed a three year agreement with Medline Industries for the distribution of Biomerica’s EZ Detect™ colorectal [...]
electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults
28/11/2018
BASKING RIDGE, N.J., Nov. 28, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it received 510(k) clearance from the U.S. Food and Drug [...]
Medical Leaders Join BioSig Clinical Advisory Board
28/11/2018
New Physician Board to Drive Adoption of PURE EP System Santa Monica, CA, Nov. 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical [...]
CASMED to Present at the 11th Annual LD Micro Main Event Conference on December 5
28/11/2018
BRANFORD, Conn., Nov. 28, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief [...]
Pascal Biosciences Expands Leadership Team to Support Strategic Advancement of Its Cannabinoid Based Programs
28/11/2018
VANCOUVER, B.C. and SEATTLE, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the strengthening of its [...]
Progressive Care Signs Letter of Intent to Purchase Florida Based Pharmacy with $18 million in Annual Revenue
28/11/2018
MIAMI, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has entered into a letter of intent to purchase a [...]
InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia
28/11/2018
Commercial Launch to Occur Immediately TEL AVIV, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke [...]
WishBone Medical, Inc. acquires Response Ortho
28/11/2018
WARSAW, Ind., Nov. 28, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. announces the acquisition of Response Ortho. Response Ortho has a complete pediatric line of external and internal fixation and deformity correction [...]
Mustang Bio Announces Presentation of MB-102 (CD123 CAR) Safety and Efficacy Data at AACR Special Conference on Tumor Immunology and Immunotherapy
28/11/2018
Research partner City of Hope to present initial safety and efficacy Phase 1 data in relapsed or refractory acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE [...]
Minerva Neurosciences Announces New Patent Application for MIN-117 Related to Broad Effect on Pain
28/11/2018
WALTHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
Pluristem to Present First Cohort Data from PLX-R18 Hematological Study at American Society of Hematology’s (ASH) Annual Meeting
28/11/2018
Clinical data from the first cohort of Phase I study for the treatment of incomplete hematopoietic recovery following hematopoietic cell transplantation Program was granted an FDA Orphan Drug Designation HAIFA, Israel, [...]
INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing
28/11/2018
The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands into new markets VANCOUVER, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- bioLytical Laboratories , a world leader in rapid infectious [...]
Diplomat Selects Inovalon’s Specialty Pharmacy Platform
28/11/2018
Nation’s Largest Independent Provider of Specialty Pharmacy Services to Leverage ScriptMed® Enterprise to Support Operations and Improved Patient Care BOWIE, Md., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV [...]
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
28/11/2018
Company anticipates review process could take up to six months FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and [...]
Share Capital and Votes
28/11/2018
November 28, 2018 Announcement no. 24 Share Capital and Votes Pursuant to section 32 of the Danish Capital Markets Act, it is hereby announced, that BioPorto A/S’ total share capital amounts to DKK 165,687,798 divided [...]
Moleculin Announces New Data Further Supporting Its Lead Drug for Treating Pancreatic Cancer
28/11/2018
WP1732 shown to accumulate beneficially in pancreas HOUSTON, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on [...]
Alliqua BioMedical to spin off and merge its Contract Manufacturing Business with TO Pharmaceuticals LLC to Create an Independent, Publicly Traded Company focused on Cannabinoid-Based Pharmaceutical Therapies
28/11/2018
LANGHORNE, Pa., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company (“TOP”), today announced plans for [...]
Kura Oncology Announces New Patent for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
28/11/2018
– AITL patent expands protection for tipifarnib, provides exclusivity in U.S. to 2037 – – Prospective data from AITL and CXCL12+ cohorts in Phase 2 trial of tipifarnib in PTCL upcoming at ASH 2018 – SAN DIEGO, Nov. 28, [...]

Pages